NCT06960395 2026-04-13
Safety and Preliminary Efficacy of VIR-5525 and VIR-5525 + Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
Vir Biotechnology, Inc.
Phase 1 Recruiting
Clinical Trials
9 trialsNCT07207707 2026-03-13
A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies
Kumquat Biosciences Inc.
Phase 1 Recruiting
NCT06994806 2026-03-03
A Study to Investigate the Safety and Efficacy of KQB168 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
Kumquat Biosciences Inc.
Phase 1 Recruiting
NCT07363967 2026-01-23
A Phase I First-in-Human Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-Tumor Activity of SWA1211 Tablets in Subjects With Advanced Solid Tumors
Beijing StoneWise Technology Co., Ltd
Phase 1 Recruiting
NCT07128914 2025-12-19
A Clinical Study of GO306 in Patients With Advanced Solid Tumors
GeneSail Biotech (Shanghai) Co., Ltd.
Phase 1 Recruiting
NCT07071090 2025-07-23
A Study of DC50292A Tablet in Patients With MTAP-deleted Advanced or Metastatic Solid Tumors
Heronova Pharmaceuticals
Phase 1 Recruiting
NCT07045428 2025-07-03
68Ga-GP-01 Injection in Solid Tumors Participants
GrandPharma (China) Co., Ltd.
Phase 1 Not yet recruiting
NCT01290380 2011-09-02
A Study to Evaluate the Effects of ASA404 Alone or in Combination With Taxane-based Chemotherapies on the Pharmacokinetics of Drugs in Patients With Advanced Solid Tumor Malignancies
Novartis
Phase 1 Terminated
NCT00195156 2006-09-14
Treatment With ATRA-IV and Depakote in Patients With Advanced Solid Tumor Malignancies
Weill Medical College of Cornell University
Phase 1 Terminated